Impact of chemotherapy-induced neurotoxicities on adult cancer survivors’ symptom burden and quality of life
- 225 Downloads
Limited information is available on the impact of chemotherapy (CTX)-induced neurotoxicity on adult survivors’ symptom experience and quality of life (QOL). Purposes were to describe occurrence of hearing loss and tinnitus and evaluate for differences in phenotypic characteristics and measures of sensation, balance, perceived stress, symptom burden, and QOL between survivors who received neurotoxic CTX and did (i.e., neurotoxicity group) and did not (i.e., no neurotoxicity group) develop neurotoxicity. Neurotoxicity was defined as the presence of chemotherapy-induced neuropathy (CIN), hearing loss, and tinnitus. Survivors in the no neurotoxicity group had none of these conditions.
Survivors (n = 609) completed questionnaires that evaluated hearing loss, tinnitus, stress, symptoms, and QOL. Objective measures of sensation and balance were evaluated.
Of the 609 survivors evaluated, 68.6% did and 31.4% did not have CIN. Of the survivors without CIN, 42.4% reported either hearing loss and/or tinnitus and 48.1% of the survivors with CIN reported some form of ototoxicity. Compared to the no neurotoxicity group (n = 110), survivors in the neurotoxicity group (n = 85) were older, were less likely to be employed, had a higher comorbidity burden, and a higher symptom burden, higher levels of perceived stress, and poorer QOL (all p < .05).
Findings suggest that CIN, hearing loss, and tinnitus are relatively common conditions in survivors who received neurotoxic CTX.
Implications for cancer survivors
Survivors need to be evaluated for these neurotoxicities and receive appropriate interventions. Referrals to audiologists and physical therapists are warranted to improve survivors’ hearing ability, functional status, and QOL.
KeywordsChemotherapy Peripheral neuropathy Hearing loss Tinnitus Balance Survivor
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Recruitment was facilitated by Dr. Susan Love Research Foundation’s Army of Women® Program.
- 4.Brock PR, Knight KR, Freyer DR, Campbell KC, Steyger PS, Blakley BW, et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol. 2012;30(19):2408–17. https://doi.org/10.1200/JCO.2011.39.1110.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712–20. https://doi.org/10.1200/JCO.2016.66.8822.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1997;123(9):978–81. https://doi.org/10.1001/archotol.1997.01900090094014.CrossRefPubMedGoogle Scholar
- 30.Karnofsky D. Performance scale. Factors that influence the therapeutic response in cancer: a comprehensive treatise. New York: Plenum Press; 1977.Google Scholar
- 31.Karnofsky D, Abelmann WH, Craver LV, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948;1(4):634–56. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L.CrossRefGoogle Scholar
- 32.Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, et al. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer. 2008;113(8):2205–14. https://doi.org/10.1002/cncr.23856.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun BT, Stucki G. Identification of candidate categories of the International Classification of Functioning Disability and Health (ICF) for a Generic ICF Core Set based on regression modelling. BMC Med Res Methodol. 2006;6(1):36. https://doi.org/10.1186/1471–2288–6-36.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Bell-Krotoski JA. Sensibility testing with Semmes-Weinstein monofilaments. In: Hunter JM, Mackin EJ, Callahan ED, editors. Rehabilitation of the hand and upper extremity. 5th ed. St. Louis: Mosby, Inc.; 2002.Google Scholar
- 39.Duke J, McEvoy M, Sibbritt D, Guest M, Smith W, Attia J. Vibrotactile threshold measurement for detecting peripheral neuropathy: defining variability and a normal range for clinical and research use. Diabetologia. 2007;50(11):2305–12. https://doi.org/10.1007/s00125-007-0813-y.CrossRefPubMedGoogle Scholar
- 44.Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA. Manual for the state-anxiety (form Y): self evaluation questionnaire. Palo Alto: Consulting Psychologists Press; 1983.Google Scholar
- 49.Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, et al. Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol. 2008;26(4):599–605. https://doi.org/10.1200/JCO.2007.12.2838.CrossRefPubMedGoogle Scholar
- 54.Weiss DS, Marmar CR. The Impact of Event Scale-Revised. Impact of Event Scale-Revised. New York: Guilford Press; 1997.Google Scholar
- 63.Ferrell BR. The impact of pain on quality of life. A decade of research. Nurs Clin N Am. 1995;30(4):609–24.Google Scholar
- 64.SPSS. IBM SPSS for windows (version 23). Armonk: SPSS, Inc.; 2015.Google Scholar
- 65.Bainbridge KE, Wallhagen MI. Hearing loss in an aging American population: extent, impact, and management. Annu Rev Public Health. 2014;35(1):139–52. https://doi.org/10.1146/annurev-publhealth-032013-182510.CrossRefPubMedGoogle Scholar
- 70.Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66. https://doi.org/10.1007/s00520-013-1766-y.CrossRefPubMedPubMedCentralGoogle Scholar
- 72.Penedo FJ, Benedict C, Zhou ES, Rasheed M, Traeger L, Kava BR, et al. Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment. J Clin Psychol Med Settings. 2013;20(1):25–32. https://doi.org/10.1007/s10880-012-9308-1.CrossRefPubMedGoogle Scholar
- 77.Osoba D. Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults. Int J Cancer Suppl. 1999;12(S12):132–7. https://doi.org/10.1002/(SICI)1097-0215(1999)83:12+<132::AID-IJC23>3.0.CO;2-4.CrossRefPubMedGoogle Scholar